Literature DB >> 2911014

Dual mechanisms in priming of the chemoattractant-induced respiratory burst in human granulocytes. A Ca2+-dependent and a Ca2+-independent route.

L Koenderman1, M Yazdanbakhsh, D Roos, A J Verhoeven.   

Abstract

After interaction with so-called priming agents, the respiratory burst in human granulocytes does not become activated, but is enhanced upon subsequent stimulation with the chemoattractant FMLP. Investigating the mechanism of the priming reaction, we found that a transient rise in the cytosolic free calcium concentration [( Ca2+]i) suffices to irreversibly prime human granulocytes. Thus, platelet-activating factor (PAF) induced a transient increase in [Ca2+]i and primed the cells to an enhanced respiratory burst upon subsequent interaction with FMLP. Artificially, the transient rise in [Ca2+]i was mimicked by addition and subsequent removal of the Ca2+ ionophore ionomycin; this treatment too, primed the respiratory burst of the granulocytes. The priming induced by ionomycin was completely abolished when [Ca2+]i changes were buffered during exposure of the cells to the ionophore. The priming induced by PAF was only partially inhibited under [Ca2+]i-buffering conditions during priming, indicating that multiple pathways exist in the priming of granulocytes by PAF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2911014

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Studies of skin-window exudate human neutrophils: increased resistance to pentoxifylline of the respiratory burst in primed cells.

Authors:  A Carletto; D Biasi; L M Bambara; P Caramaschi; M L Bonazzi; S Lussignoli; G Andrioli; P Bellavite
Journal:  Inflammation       Date:  1997-04       Impact factor: 4.092

Review 2.  Adaptive and maladaptive mechanisms of cellular priming.

Authors:  D R Meldrum; J C Cleveland; E E Moore; D A Partrick; A Banerjee; A H Harken
Journal:  Ann Surg       Date:  1997-11       Impact factor: 12.969

3.  Moderate exercise improves leucocyte function and decreases inflammation in diabetes.

Authors:  M F Belotto; J Magdalon; H G Rodrigues; M A R Vinolo; R Curi; T C Pithon-Curi; E Hatanaka
Journal:  Clin Exp Immunol       Date:  2010-09-15       Impact factor: 4.330

4.  Assessment of oxidative stress in chronic pancreatitis patients.

Authors:  Mariette Verlaan; Hennie M J Roelofs; Annie van-Schaik; Geert J A Wanten; Jan B M J Jansen; Wilbert H M Peters; Joost P H Drenth
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

5.  Human airway eosinophils respond to chemoattractants with greater eosinophil-derived neurotoxin release, adherence to fibronectin, and activation of the Ras-ERK pathway when compared with blood eosinophils.

Authors:  Mary Ellen Bates; Julie B Sedgwick; Yiming Zhu; Lin Ying Liu; Rose G Heuser; Nizar N Jarjour; Hirohito Kita; Paul J Bertics
Journal:  J Immunol       Date:  2010-05-21       Impact factor: 5.422

6.  Nimesulide inhibits platelet-activating factor synthesis in activated human neutrophils.

Authors:  A J Verhoeven; A T Tool; T W Kuijpers; D Roos
Journal:  Drugs       Date:  1993       Impact factor: 9.546

7.  Superoxide production by human eosinophils can be inhibited in an agonist-selective manner.

Authors:  M K Bach; J R Brashler; E N Petzold; M E Sanders
Journal:  Agents Actions       Date:  1992-01

8.  The influence of tetracyclines on T cell activation.

Authors:  M Kloppenburg; C L Verweij; A M Miltenburg; A J Verhoeven; M R Daha; B A Dijkmans; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

9.  FMLP is a potent activator of guinea-pig eosinophils but its activity is dependent on the prior overnight in vitro culture of the cells (facilitation).

Authors:  M K Bach; J R Brashler
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

10.  Oleic, linoleic and linolenic acids increase ros production by fibroblasts via NADPH oxidase activation.

Authors:  Elaine Hatanaka; Alexandre Dermargos; Aparecida Emiko Hirata; Marco Aurélio Ramirez Vinolo; Angelo Rafael Carpinelli; Philip Newsholme; Hugo Aguirre Armelin; Rui Curi
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.